Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna MRNA we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 62% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $297,052 and 6, calls, for a total amount of $238,315.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $135.0 for Moderna over the last 3 months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Moderna's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Moderna's significant trades, within a strike price range of $80.0 to $135.0, over the past month.
Moderna Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | SWEEP | BEARISH | 03/15/24 | $85.00 | $160.0K | 1.1K | 501 |
| MRNA | PUT | SWEEP | BEARISH | 03/15/24 | $85.00 | $137.0K | 1.1K | 1.0K |
| MRNA | CALL | SWEEP | BULLISH | 01/19/24 | $86.00 | $61.5K | 121 | 50 |
| MRNA | CALL | SWEEP | BEARISH | 02/16/24 | $100.00 | $56.5K | 1.1K | 182 |
| MRNA | CALL | TRADE | BULLISH | 02/16/24 | $100.00 | $30.7K | 1.1K | 298 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Moderna Standing Right Now?
- Currently trading with a volume of 1,892,305, the MRNA's price is down by -1.48%, now at $98.87.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 35 days.
What The Experts Say On Moderna
In the last month, 2 experts released ratings on this stock with an average target price of $133.5.
- An analyst from Oppenheimer upgraded its action to Outperform with a price target of $142.
- Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $125.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
